Search your symptoms with MEDgle. You can check your symptoms. It is a medical symptom search allowing you find out what options make sense for you.
CLOSE
PATIENT GPS
patients
healthcare providers
how it works
about
login
edit search
new search
symptoms
diagnoses
physicians
drugs
procedures
close
symptoms
diagnoses
drugs
procedures
physicians
symptom duration
0-3 days
4-14 days
2 weeks-2 months
2-6 months
6 months +
add symptom to current symptom search
same as above
0-3 days
4-14 days
2 weeks-2 months
2-6 months
6 months +
add symptom to current symptom search
same as above
0-3 days
4-14 days
2 weeks-2 months
2-6 months
6 months +
add symptom to current symptom search
same as above
0-3 days
4-14 days
2 weeks-2 months
2-6 months
6 months +
gender
male
female
age
1-3
4-11
12-17
18-29
30-50
50+
age
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
calculate
visual
[hide visual search]
search visually
symptoms
|
diagnoses
|
drugs
|
procedures
|
physicians
search symptoms
•
Find causes for your symptoms
•
Discover relevant types of physicians
search diagnoses
•
Understand the details of a diagnosis
•
Learn about relevant tests and treatments
•
Find useful resources on the web
search drugs
•
Learn about different therapeutic drugs
•
Understand what they are used for
•
Know the potential options
search procedures
•
Learn about different diagnostic and therapeutic procedures
•
Understand what they are used for
•
Know the potential options
search physicians
•
Find physicians in your area
•
Understand what they do
•
Get the right help you need
gl-3 (globotriaosylceramide) levels plasma
reduced results from
147 billion
41 million
6910
4
to ~6 options
options split into images, definition, symptoms, related diagnoses, diagnostic tests, therapies, and medications
what is 'gl-3 (globotriaosylceramide) levels plasma'?
Definition for GL-3 (globotriaosylceramide) levels plasma
GL-3 (globotriaosylceramide) levels plasma is a medical procedure used for such diagnoses as: Fabry's disease.
related diagnosis for 'gl-3 (globotriaosylceramide) levels plasma'
1 - 1 of
1
diagnosis
Fabry's disease
genetic disorder of glycolipid metabolism
GL-3 (globotriaosylceramide) levels plasma and Fabry's disease
related procedure for 'gl-3 (globotriaosylceramide) levels plasma'/associated diagnoses
1 - 1 of
1
procedures
cultured skin fibroblasts for biochemical study
GL-3 (globotriaosylceramide) levels plasma and cultured skin fibroblasts for biochemical study
related medication for 'gl-3 (globotriaosylceramide) levels plasma'/associated diagnoses
1 - 1 of
1
drugs
agalsidase beta
GL-3 (globotriaosylceramide) levels plasma and agalsidase beta
carbamazepine
GL-3 (globotriaosylceramide) levels plasma and carbamazepine
gabapentin
GL-3 (globotriaosylceramide) levels plasma and gabapentin
phenytoin
GL-3 (globotriaosylceramide) levels plasma and phenytoin
The following are types of physicians relevant for 'GL-3 (globotriaosylceramide) levels plasma'.
related types of physicians 'family practitioner, genetics specialist, internist, metabolic specialist'
show local physicians
postal code
Find Local
stars represent relevance to topic not rating
more
The results are computer generated suggestions to help you find a physician. MEDgle does not recommend any particular type of physician or claim to be complete or accurate in the providers and specialties suggested.
web search results for 'gl-3 (globotriaosylceramide) levels plasma'?
Results
1 - 50
- GL-3 (globotriaosylceramide) levels plasma
Long-term safety and efficacy of enzyme replacement therapy for Fabry ...
... plasma globotriaosylceramide (GL-3) levels during 30 mo of the extension study ... GL-3 levels, sustained endothelial GL-3 clearance, stable kidney ...
http://www.ncbi.nlm.nih.gov/pubmed/15154115
www.ncbi.nlm.nih.gov
-
summary
Fabry Disease: Preclinical Studies Demonstrate the Effectiveness of ? ...
Importantly, the globotriaosylceramide (GL-3) substrate was depleted in various ... mg/kg reduced the plasma GL-3 to wild-type levels, which were maintained on day ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1234907
www.pubmedcentral.nih.gov
-
summary
Treatment of Fabry Disease: Outcome of a Comparative Trial with ...
... antibodies, and globotriaosylceramide levels in plasma and urine. ... Levels of GL-3 in plasma were measured by high pressure liquid chromatography ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1913555
www.pubmedcentral.nih.gov
-
summary
Short-Term Efficacy of Enzyme Replacement Therapy in Korean Patients ...
Plasma and urine globotriaosylceramide (GL-3) levels, serum creatinine, ... Plasma and urine GL-3 levels were reduced within 3 to 6 months of ERT initiation. ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2526436
www.pubmedcentral.nih.gov
-
summary
Long-Term Safety and Efficacy of Enzyme Replacement Therapyfor Fabry ...
... of globotriaosylceramide (GL-3) and related glycosphingolipids in the ... In addition, the plasma GL-3 levels normalized and the mean serum creatinine and ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pub...
www.pubmedcentral.nih.gov
-
summary
Fabry Disease -- GeneReviews -- NCBI Bookshelf
... deposition of globotriaosylceramide (GL-3) in cells throughout ... In individuals treated with enzyme, plasma levels of GL-3 decreased into normal range. ...
http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gene&part=fabry
www.ncbi.nlm.nih.gov
-
summary
UMOD-Related Kidney Disease -- GeneReviews -- NCBI Bookshelf
... lysosomal deposition of globotriaosylceramide (GL-3) in cells throughout the body. ... Plasma uric acid levels in children. Arch Dis Child. 1969; 44: 773?8. ...
http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gene&part=mckd2
www.ncbi.nlm.nih.gov
-
summary
Fabry Disease
In individuals treated with enzyme, plasma levels. of GL-3 decreased into normal range. ... Globotriaosylceramide accumulation in the Fabry kidney is cleared ...
http://www.ncbi.nlm.nih.gov/bookshelf/picrender.fcgi?book=ge...
www.ncbi.nlm.nih.gov
-
summary
Correction of enzymatic and lysosomal storage defects in Fabry mice by ...
... of the glycosphingolipid globotriaosylceramide (GL-3) in the vascular lysosomes, ... in GL-3 content in all tissues to near normal levels for up to 6 ...
http://www.be-md.ncbi.nlm.nih.gov/pubmed/10428212
www.be-md.ncbi.nlm.nih.gov
-
summary
Treatment of Fabry disease with different dosing regimens of agalsidase ...
... A antibodies and their effect on urinary and plasma globotriaosylceramide (GL ... Levels of plasma GL-3 and chitotriosidase decreased in all patient groups. ...
http://www.ncbi.nlm.nih.gov/pubmed/18424138?dopt=Abstract
www.ncbi.nlm.nih.gov
-
summary
Fabry Disease: Novel ?-Galactosidase A 3?-Terminal Mutations Result in ...
However, the finding of similar levels of nuclear and cytoplasmic ?-GalA mRNA in ... (primarily globotriaosylceramide [GL-3]) in the plasma and in the lysosomes of ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1180577
www.pubmedcentral.nih.gov
-
summary
This Month in the Journal
... systems, which are due to the accumulation of globotriaosylceramide (GL-3) ... plasma GL-3. Clearance of GL-3 from tissues was more variable but generally ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1274499
www.pubmedcentral.nih.gov
-
summary
Methotrexate reduces antibody responses to recombinant human ? ...
... substrate, globotriaosylceramide (GL-3) in lysosomes of vascular endothelial ... time these mice accumulate GL-3 in tissues including plasma, liver, heart and ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1809149
www.pubmedcentral.nih.gov
-
summary
p38 Mitogen-Activated Protein Kinase Mediates Lipopolysaccharide and ...
... (Gb3), CD77, Pk antigen, or GL-3 (50), and enter the target cell via receptor ... Plasma cytokine levels in hemolytic uremic syndrome. Nephron 71:309-313. ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2258847
www.pubmedcentral.nih.gov
-
summary
Elevated globotriaosylsphingosine is a hallmark of Fabry disease
Plasma globotriaosylceramide levels are reduced by therapy. ... formation on reduction of globotriaosylceramide (GL-3) in urine from Fabry ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2268542
www.pubmedcentral.nih.gov
-
summary
A Phase 1/2 Clinical Trial of Enzyme Replacement in Fabry Disease ...
... the globotriaosylceramide (GL-3) and related glycosphingolipids, primarily in ... Plasma GL-3 levels were measured at baseline, before each infusion, and either ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pub...
www.pubmedcentral.nih.gov
-
summary
UMOD-Related Kidney Disease
(GL-3) in cells throughout the body. The classic form, occurring in males with less than 1 ... Plasma uric acid levels in children. Arch Dis Child. 1969;44:773 ...
http://www.ncbi.nlm.nih.gov/bookshelf/picrender.fcgi?book=ge...
www.ncbi.nlm.nih.gov
-
summary
This Month in the Journal
... of accumulated globotriaosylceramide (GL-3) to normal levels in the ... the extension study have continued to exhibit normal mean plasma GL-3 levels and ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1182014
www.pubmedcentral.nih.gov
-
summary
Local entrapment of interferon gamma in the recovery from Shigella ...
Journal List > Gut > v.38(3); Mar 1996. Summary. Selected References. Page Browse ... Hammond GL. ... of the verocytotoxin receptor globotriaosylceramide ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1383059
www.pubmedcentral.nih.gov
-
summary
"Alternative" Endocytic Mechanisms Exploited by Pathogens
MVBs can either fuse with the lysosome or with the plasma membrane. ... globotriaosylceramide (Gb(3)) to effect nuclear targeting of exogenous DNA in Gb ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2040389
www.pubmedcentral.nih.gov
-
summary
Tumor-Specific Hsp70 Plasma Membrane Localization Is Enabled by the ...
... than their counterparts which express low levels of membrane-bound Hsp70 [3], [5] ... Globotriaosylceramide content is significantly higher in Hsp70 ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2271151
www.pubmedcentral.nih.gov
-
summary
Short-Term Efficacy of Enzyme Replacement Therapy in Korean Patients ...
Plasma and urine globotriaosylceramide (GL-3) levels, serum creatinine, ... Plasma and urine GL-3 levels were reduced within 3 to 6 months of ERT initiation. ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=25...
www.pubmedcentral.nih.gov
-
summary
Abnormal germinal center reactions in systemic lupus erythematosus ...
... levels, and continued 3 months after treatment to 80% ± 25% (range 60?122%) of ... levels that paralleled the disappearance of CD38bright IC Ig+ plasma ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pub...
www.pubmedcentral.nih.gov
-
summary
Differential responses of human B-lymphocyte subpopulations to graded ...
... were monitored in response to graded levels of CD40 stimulation in the presence ... (up to 20%) differentiated towards plasma cells, as ... Figure 3 ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pub...
www.pubmedcentral.nih.gov
-
summary
High Incidence of Later-Onset Fabry Disease Revealed by Newborn Screening
... globotriaosylceramide (GL-3) and related glycosphingolipids, particularly in ... alleles had low levels of activity (<5% of normal) in the plasma or tissues of ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pub...
www.pubmedcentral.nih.gov
-
summary
show more
1
Chat with eNurse Kim about 'GL-3 (globotriaosylceramide) levels plasma' or something else!
quick facts
related diagnosis category
genetic or congenital
metabolic
faq/about
|
disclaimer
|
privacy policy
|
terms of service
|
browse
|
beta
|
contact
|
API - Catalyst
MEDgle does not provide medical advice, diagnosis or treatment. Copyright 2006-2012, MEDgle Inc. All Rights Reserved. MEDgle is NOT affiliated with Google. Last Updated: Mar 14, 2012
This site complies to the
HONcode standard for trustworthy health
information:
verify here
.
Invited Sponsor for Communications Conference
Finalist -- search & reference
MEDgle has been selected for the 2009 Best of Business Award in the Medical research